CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (84,461)	$ (4,987)	$ (69,752)
Net income from discontinued operations	(197)	(84,923)	(11,867)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	49,018	37,907	27,014
Accretion of debt in interest expense, net	2,342	2,432	2,205
Accretion of discount on held to maturity investments in interest expense, net	0	480	(1,886)
Current expected credit losses	4,334	2,596	579
Provision for obsolete inventory	1,266	(150)	(1,915)
Stock-based compensation	30,645	24,487	14,291
Impairment loss	3,555	225	0
Loss on debt extinguishment	5,791	6,560	635
Adjustment to contingent consideration liability	0	(600)	(9,200)
Deferred income tax	(535)	(10,788)	197
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(25,889)	(10,496)	(772)
Inventories	(6,520)	1,768	15,984
Other current assets	(15,236)	(3,390)	(1,147)
Other assets	2,793	30	(1,608)
Accounts payable	3,979	4,276	4,411
Accrued salaries and benefits	2,483	8,101	(265)
Accrued expenses	(3,174)	2,476	769
Customer deposits and deferred service revenue	2,023	(318)	(2,179)
Customers payable	692	3,258	2,966
Other long-term liabilities	(67)	(257)	(412)
Cash used in operating activities - continuing operations	(27,158)	(21,313)	(31,952)
Cash (used in) provided by operating activities - discontinued operations	0	(3,933)	14,877
Net cash used in operating activities	(27,158)	(25,246)	(17,075)
Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired	(4,323)	(309,368)	(1,900)
Capital expenditures	(3,323)	(970)	(5,018)
Capitalization of software costs	(5,618)	(5,814)	(5,346)
Proceeds from company owned life insurance policies	0	3,266	0
Proceeds from sale of held to maturity investments	310	65,065	85,978
Purchases of held to maturity investments	(351)	(28,351)	(80,996)
Cash used in investing activities - continuing operations	(13,305)	(276,172)	(7,282)
Cash provided by (used in) investing activities - discontinued operations	197	96,060	(499)
Net cash used in investing activities	(13,108)	(180,112)	(7,781)
Cash flows from financing activities:
Principal payments of long-term debt	(93,600)	0	0
Proceeds from private placement of common stock, net of issuance costs	0	194,490	0
Proceeds from debt issuance, net of original issue discount	111,136	87,333	0
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock	(7,043)	(5,071)	(2,685)
Proceeds from exercise of stock options	466	2,235	1,069
Proceeds from employee stock purchase plan	1,311	989	0
Cash paid for debt extinguishment	0	(1,469)	0
Net cash provided by (used in) financing activities	12,270	278,507	(1,616)
Effect of exchange rate changes on cash and cash equivalents	136	857	(3,522)
Net (decrease) increase in cash, cash equivalents, and cash held on behalf of customers	(27,860)	74,006	(29,994)
Cash, cash equivalents, and cash held on behalf of customers at beginning of period	121,545	47,539	77,533
Cash, cash equivalents, and cash held on behalf of customers at end of period	93,685	121,545	47,539
Reconciliation of cash, cash equivalents, and cash held on behalf of customers
Cash and cash equivalents	79,565	108,117	37,369
Cash held on behalf of customers	14,120	13,428	10,170
Total cash, cash equivalents, and cash held on behalf of customers	93,685	121,545	47,539
Supplemental disclosures of cash flow information:
Cash paid for income taxes	5,763	2,323	3,223
Capitalized software recorded in accounts payable	56	31	38
Capital expenditures in accounts payable	210	76	139
Common stock issued for acquisition	$ 108,182	$ 133,180	$ 0